Society guideline links: Cerebral palsy

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Dystonia in children and adults" and "Society guideline links: Developmental screening".)

International

●Interventions to improve physical function for children and young people with cerebral palsy – International clinical practice guideline (2022)

●Early intervention for children aged 0 to 2 years with or at high risk of cerebral palsy – International clinical practice guideline (2021)

●Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy – International consensus statement (2010)

Canada

●Canadian Paediatric Society (CPS): Position statement on mental health problems in children with neuromotor disabilities (2016, reaffirmed 2022)

●CPS: Practice point on comprehensive care of the ambulatory child with cerebral palsy (GMFCS I and II) – A Canadian perspective (2020)

●CPS: Practice point on nutritional evaluation of the neurologically impaired child (2020)

●Society of Obstetricians and Gynaecologists of Canada (SOGC): Clinical practice guideline on magnesium sulphate for fetal neuroprotection (2019)

United States

●American Academy of Neurology (AAN) and Child Neurology Society (CNS): Practice parameter – Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review) (2010, reaffirmed 2022)

●American Academy of Pediatrics (AAP): Clinical report on providing a primary care medical home for children and youth with cerebral palsy (2022)

●American College of Obstetricians and Gynecologists (ACOG): Committee opinion on magnesium sulfate before anticipated preterm birth for neuroprotection (2010, reaffirmed 2020)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Quality standard on cerebral palsy in adults (2020)

●NICE: Guideline on cerebral palsy in adults (2019)

●NICE: Guideline on cerebral palsy in under 25s – Assessment and management (2017)

●NICE: Quality standard on cerebral palsy in children and young people (2017)

●NICE: Interventional procedures guidance on selective dorsal rhizotomy for spasticity in cerebral palsy (2010)

Australia–New Zealand

●National clinical practice guidelines on antenatal magnesium sulphate prior to preterm birth for neuroprotection of the fetus, infant and child (2010)

Japan

●[In Japanese] Japanese Association of Rehabilitation Medicine (JARM): Japanese guidelines for rehabilitation of cerebral palsy, 2nd edition (2014)